Results 11 to 20 of about 132,451 (332)

Nanomedicine Approaches for Corneal Diseases [PDF]

open access: yesJournal of Functional Biomaterials, 2015
Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions.
Shyam S. Chaurasia   +3 more
doaj   +5 more sources

Corneal Opacity in LCAT Disease [PDF]

open access: greenCornea, 1992
Deficiency of lecithin:cholesterol acyltransferase, LCAT disease, is one of the dyslipoproteinemias with characteristic lipid deposits in the cornea. The present report documents the clinicopathologic abnormalities of one case in which a full-thickness corneal specimen was obtained at the time of corneal transplantation.
David G. Cogan   +3 more
openalex   +5 more sources

Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases. [PDF]

open access: yesFront Pharmacol, 2021
Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a useful treatment option for not only corneal ectasias, such as keratoconus, but also a number of other corneal diseases. Riboflavin is a photoactivated chromophore that plays an integral role in facilitating collagen crosslinking.
Wu D   +6 more
europepmc   +6 more sources

Metabolomics in Corneal Diseases: A Narrative Review from Clinical Aspects [PDF]

open access: yesMetabolites, 2023
Corneal pathologies may have subtle manifestations in the initial stages, delaying diagnosis and timely treatment. This can lead to irreversible visual loss.
Alvin Wei Jun Teo   +3 more
doaj   +2 more sources

Methylation in cornea and corneal diseases: a systematic review [PDF]

open access: yesCell Death Discovery
Corneal diseases are among the primary causes of blindness and vision loss worldwide. However, the pathogenesis of corneal diseases remains elusive, and diagnostic and therapeutic tools are limited.
Yutong Xia   +11 more
doaj   +2 more sources

Cell Therapy of Corneal Diseases. [PDF]

open access: yesCornea, 2016
Mesenchymal stem cells isolated from connective tissues are pluripotent and differentiate into phenotypes of connective tissue cell lineages (osteoblasts, chondrocytes, and adipocytes) in vitro and in vivo. They have been used to treat mouse models of connective tissue disease such as lumican-null (Lum) and mucopolysaccharidosis (Gusb) mice ...
Kao WW, Coulson-Thomas VJ.
europepmc   +4 more sources

Corneal Disease & Transplantation

open access: yesJournal of Clinical Medicine, 2022
Corneal diseases represent the third leading cause of blindness worldwide, and corneal transplantation, which aims at restoring corneal clarity and vision, is the most frequently performed transplant worldwide [...]
Giulia Coco, Vito Romano
openaire   +5 more sources

Early Visibility of Cellular Aggregates and Changes in Central Corneal Thickness as Predictors of Successful Corneal Endothelial Cell Injection Therapy

open access: yesCells, 2023
(1) Background: Cell injection therapy is an emerging treatment for bullous keratopathy (BK). Anterior segment optical coherence tomography (AS-OCT) imaging allows the high-resolution assessment of the anterior chamber. Our study aimed to investigate the
Evan N. Wong   +7 more
doaj   +1 more source

The Effects of Donor-Recipient Age and Sex Compatibility in the Outcomes of Deep Anterior Lamellar Keratoplasties

open access: yesFrontiers in Medicine, 2022
PurposeCorneal transplantations are the commonest allogenic transplant surgeries performed worldwide. Transplantable grade donor cornea is a finite resource.
Hon Shing Ong   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy